🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this randomized clinical trial is to learn if topical treatment...
Status
Recruiting
Location
Genesis Cancer and Blood Institute
Start Date
2025-08-25
Trial ID
NCT06830863
The first testing of TargomiRs in the human setting: dose-finding studies i...
Status
Completed
Location
Concord Repatriation General Hospital
Start Date
2014-09
Trial ID
NCT02369198
Treatments Being Tested
Dyspepsia refers to chronic or recurrent upper gastrointestinal (GI) sympto...
Status
Recruiting
Location
KU Leuven
Start Date
2024-10-01
Trial ID
NCT06482671
Treatments Being Tested
This Phase III study is designed to evaluate the efficacy and safety of KX2...
Status
Completed
Location
Coastal Clinical Research, Inc.
Start Date
2017-09-18
Trial ID
NCT03285477
Treatments Being Tested
This is a phase II, double blind study with ZEP-3NA 0.1% or 1% vs. vehicle-...
Status
Unknown
Location
Ha'Emek MC
Start Date
2019-12-29
Trial ID
NCT04307862
Treatments Being Tested
The purpose of this study is to compare the efficacy of Photodynamic Therap...
Status
Completed
Location
Spencer Dermatology and Skin Surgery
Start Date
2007-09
Trial ID
NCT00306800
Treatments Being Tested
This is a double-blinded, randomized, pharmacokinetic and safety study of 3...
Status
Completed
Location
Johns Hopkins University, Division of Clinical Pharmacology, Drug Development Unit
Start Date
2013-03
Trial ID
NCT01575418
To demonstrate therapeutic equivalence and safety of Trifarotene cream 0.00...
Status
Completed
Location
Taro Pharmaceuticals USA Inc.
Start Date
2023-02-22
Trial ID
NCT06063473
Treatments Being Tested
This is a Phase III, multicenter, randomized, placebo-controlled trial desi...
Status
Unknown
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT00262067
Treatments Being Tested